Danaher vs Vertex Pharmaceuticals
Danaher (DHR), health care, and Vertex Pharmaceuticals (VRTX), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Danaher is worth $159.2B on the stock market and Vertex Pharmaceuticals $135.1B: Danaher is valued at 18% more. Danaher trades at 37.5 times earnings and Vertex Pharmaceuticals at 34.3; operating margins in their latest fiscal years were 19.1% and 34.8%. Over the past year Danaher's share price has moved +1.95% and Vertex Pharmaceuticals's +23.5%.
Key facts
- Danaher market value
- $159.2B
- Vertex Pharmaceuticals market value
- $135.1B
- Danaher P/E
- 37.5
- Vertex Pharmaceuticals P/E
- 34.3
- Danaher revenue
- $24.6BFY to 2025-12-31
- Vertex Pharmaceuticals revenue
- $12BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Danaher | Vertex Pharmaceuticals |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $159.2Bhigher | $135.1Blower |
| Revenue | $24.6Bhigher | $12Blower |
| Earnings | $3.6Blower | $4Bhigher |
| Employees | 58,000higher | 6,400lower |
| Total assets | $83.5Bhigher | $25.6Blower |
| Valuation | ||
| P/E | 37.5higher | 34.3lower |
| P/S | 6.5lower | 11.3higher |
| P/B | 3.0lower | 6.5higher |
| Dividend yield | 0.66%higher | 0.00%lower |
| Profitability | ||
| Operating margin | 19.1%lower | 34.8%higher |
| Balance sheet | ||
| Net assets | $52.5Bhigher | $18.7Blower |
| Total liabilities | $30.9Bhigher | $7Blower |
| Total debt | $18.4B | — |
| Cash on hand | $4.6Blower | $5.1Bhigher |
| Price change | ||
| Today | -1.57%lower | -0.91%higher |
| 1 year | +1.95%lower | +23.5%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Israel Englander0.3% / 0.2%
Danaher only (18)
- Wallace Weitz7.0%
- Eric Bannasch4.8%
- Larry Robbins4.4%
- Doug Silverman2.3%
- Dan Loeb2.2%
- Daniel Sundheim2.1%
- Brandon Haley1.6%
- Steven Romick1.5%
- Dodge & Cox team1.2%
- Chase Coleman0.4%
- Ken Fisher0.3%
- Primecap team0.3%
- Louis Bacon0.2%
- Stanley Druckenmiller0.2%
- Bill Gates0.2%
- Cliff Asness0.2%
- Rajiv Jain<0.1%
- Bill Nygren<0.1%
Vertex Pharmaceuticals only (4)
Percentages are each holding's share of that investor's reported portfolio (under "Both": Danaher / Vertex Pharmaceuticals). Who owns DHR · Who owns VRTX
More on Danaher
Further comparisons
Danaher against its closest peers
Vertex Pharmaceuticals against its closest peers
Learn
Questions and answers
Which is bigger, Danaher or Vertex Pharmaceuticals?
By market value, Danaher is the larger: $159.2B against $135.1B for Vertex Pharmaceuticals. By revenue in its latest fiscal year, Danaher is the larger: $24.6B against $12B for Vertex Pharmaceuticals.
Which has the higher P/E ratio?
Danaher: 37.5, against 34.3 for Vertex Pharmaceuticals. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Vertex Pharmaceuticals: 34.8%, against 19.1% for Danaher. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Danaher: 0.66%, against 0.00% for Vertex Pharmaceuticals. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Danaher and Vertex Pharmaceuticals?
In their latest 13F filings, Israel Englander holds both.
Cite this page
Funkfolio, “Danaher vs Vertex Pharmaceuticals”, data as of 17 November 2026. https://funkfolio.com/compare/dhr-vs-vrtx
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.